Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.

× No keyword cloud information.

36 in total

Review 1. Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates.

Authors: Antonio Coppola; Annarita Tagliaferri; Gabriele Calizzani; Fabio Candura; Massimo Franchini; Carlo Ruosi; Giuliano Grazzini; Giovanni Di Minno
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

2. Correction of knee flexion contracture at the time of surgical fixation of a femoral supracondylar fracture in a haemophiliac with inhibitors.

Authors: Laura Candiotto; Franco W Fullone; Alberto Ricciardi; Paolo Radossi; Giuseppe Tagariello
Journal: Blood Transfus Date: 2014-10-23 Impact factor: 3.443

3. Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy.

Authors: Angiola Rocino; Antonio Coppola; Massimo Franchini; Giancarlo Castaman; Cristina Santoro; Ezio Zanon; Elena Santagostino; Massimo Morfini
Journal: Blood Transfus Date: 2014-10 Impact factor: 3.443

Review 4. Current and evolving features in the clinical management of haemophilia.

Authors: Antonio Coppola; Massimo Morfini; Ernesto Cimino; Antonella Tufano; Anna M Cerbone; Giovanni Di Minno
Journal: Blood Transfus Date: 2014-04 Impact factor: 3.443

5. Improving the performance of factor VIII inhibitor tests in hemophilia A.

Authors: Connie H Miller
Journal: Thromb Res Date: 2015-09-28 Impact factor: 3.944

6. National surveillance for hemophilia inhibitors in the United States: Summary report of an expert meeting.

Authors: J Michael Soucie; Connie H Miller; Fiona M Kelly; Diane Aschman; Donna DiMichele; Barbara A Konkle; Roshni Kulkarni; Paul E Monahan
Journal: Am J Hematol Date: 2014-04-10 Impact factor: 10.047

7. Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011.

Authors: Peter W Collins; Benedict P Palmer; Elizabeth A Chalmers; Daniel P Hart; Ri Liesner; Savita Rangarajan; Katherine Talks; Michael Williams; Charles R M Hay
Journal: Blood Date: 2014-10-22 Impact factor: 22.113

8. Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model.

Authors: G Batsuli; J Ito; R Mercer; W H Baldwin; C Cox; E T Parker; J F Healey; P Lollar; S L Meeks
Journal: J Thromb Haemost Date: 2018-08-13 Impact factor: 5.824

Review 9. Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.

Authors: C H Miller
Journal: Haemophilia Date: 2018-02-15 Impact factor: 4.287

10. Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats.

Authors: Shannon M Zintner; Juliana C Small; Giulia Pavani; Lynn Dankner; Oscar A Marcos-Contreras; Phyllis A Gimotty; Mads Kjelgaard-Hansen; Bo Wiinberg; Paris Margaritis
Journal: Blood Adv Date: 2019-02-12